Wu E - Search Results

1

Real-world analysis of haemophilia patients in China: A single centre's experience.

Song X, Liu W, Xue F, Zhong J, Yang Y, Liu Y, Xie J, Wu E, Zhang L, Shi J, Yang R. Song X, et al. Among authors: wu e. Haemophilia. 2020 Jul;26(4):584-590. doi: 10.1111/hae.14029. Epub 2020 May 20. Haemophilia. 2020. PMID: 32432832

2

Economic burden of psoriasis compared to the general population and stratified by disease severity.

Yu AP, Tang J, Xie J, Wu EQ, Gupta SR, Bao Y, Mulani PM. Yu AP, et al. Curr Med Res Opin. 2009 Oct;25(10):2429-38. doi: 10.1185/03007990903185557. Curr Med Res Opin. 2009. PMID: 19663687

3

Economic consequence of switching to citalopram after its generic entry for adult patients with major depressive disorder (MDD) treated with escitalopram: a 6-month retrospective study.

Yu AP, Xie J, Bensimon A, Parikh K, Wu EQ, Ben-Hamadi R, Blum S, Haim Erder M. Yu AP, et al. J Med Econ. 2010;13(4):599-609. doi: 10.3111/13696998.2010.521736. Epub 2010 Sep 29. J Med Econ. 2010. PMID: 20879834 Free article.

4

Impact of initiation timing of SSRI or SNRI on depressed adolescent healthcare utilization and costs.

Yu AP, Ben-Hamadi R, Wu EQ, Kaltenboeck A, Bergman R, Xie J, Blum S, Erder MH. Yu AP, et al. J Med Econ. 2011;14(4):508-15. doi: 10.3111/13696998.2011.593602. Epub 2011 Jun 21. J Med Econ. 2011. PMID: 21692605 Free article.

5

Economic evaluation of denosumab compared with zoledronic acid in hormone-refractory prostate cancer patients with bone metastases.

Xie J, Namjoshi M, Wu EQ, Parikh K, Diener M, Yu AP, Guo A, Culver KW. Xie J, et al. J Manag Care Pharm. 2011 Oct;17(8):621-43. doi: 10.18553/jmcp.2011.17.8.621. J Manag Care Pharm. 2011. PMID: 21942303 Free PMC article. Clinical Trial.

6

Comparative effectiveness research using matching-adjusted indirect comparison: an application to treatment with guanfacine extended release or atomoxetine in children with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder.

Signorovitch J, Erder MH, Xie J, Sikirica V, Lu M, Hodgkins PS, Wu EQ. Signorovitch J, et al. Pharmacoepidemiol Drug Saf. 2012 May;21 Suppl 2:130-7. doi: 10.1002/pds.3246. Pharmacoepidemiol Drug Saf. 2012. PMID: 22552988

7

Cost-effectiveness of denosumab compared with zoledronic acid in patients with breast cancer and bone metastases.

Xie J, Diener M, Sorg R, Wu EQ, Namjoshi M. Xie J, et al. Clin Breast Cancer. 2012 Aug;12(4):247-58. doi: 10.1016/j.clbc.2012.04.001. Epub 2012 Jun 12. Clin Breast Cancer. 2012. PMID: 22694824

8

Cost effectiveness of pharmacotherapies for attention-deficit hyperactivity disorder: a systematic literature review.

Wu EQ, Hodgkins P, Ben-Hamadi R, Setyawan J, Xie J, Sikirica V, Du EX, Yan SY, Erder MH. Wu EQ, et al. CNS Drugs. 2012 Jul 1;26(7):581-600. doi: 10.2165/11633900-000000000-00000. CNS Drugs. 2012. PMID: 22712698 Review.

9

Matching-adjusted indirect comparisons: a new tool for timely comparative effectiveness research.

Signorovitch JE, Sikirica V, Erder MH, Xie J, Lu M, Hodgkins PS, Betts KA, Wu EQ. Signorovitch JE, et al. Among authors: wu eq. Value Health. 2012 Sep-Oct;15(6):940-7. doi: 10.1016/j.jval.2012.05.004. Value Health. 2012. PMID: 22999145 Free article.

10

Budget impact analysis of everolimus for the treatment of hormone receptor positive, human epidermal growth factor receptor-2 negative (HER2-) advanced breast cancer in the United States.

Xie J, Diener M, De G, Yang H, Wu EQ, Namjoshi M. Xie J, et al. J Med Econ. 2013;16(2):278-88. doi: 10.3111/13696998.2012.749788. Epub 2012 Dec 5. J Med Econ. 2013. PMID: 23153318 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,541 results

Search Page

Filters